MariMed Inc. (MRMD.CN)
| Previous Close | 0.3600 |
| Open | 0.3900 |
| Bid | 0.3050 x N/A |
| Ask | 0.4800 x N/A |
| Day's Range | 0.3050 - 0.3900 |
| 52 Week Range | 0.2000 - 0.7800 |
| Volume | |
| Avg. Volume | 34,591 |
| Market Cap | 116.426M |
| Beta (5Y Monthly) | 2.87 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0500 |
| Earnings Date | May 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
News DirectMariMed closes acquisition of a dispensary in Illinois marking the company’s 5th in that state
MariMed CEO Jon Levine joined Steve Darling from Proactive to to share the Company’s significant developments, including its recent of Allgreens Dispensary, LLC, which closed on April 9, 2024. The ...
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Village Farms regained Nasdaq compliance; Weedmaps is facing a compliance issue. MariMed expanded Maryland presence with a $5.3 million acquisition. Tilray adjusted expectations for 2024 amid financial challenges, as they eye Canadian tax relief. Key Takeaways; Psychedelic Sector Optimi Health partnered with a New Zealand institute to supply psilocybin for indigenous […]
GlobeNewswireMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary
NORWOOD, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced the closing of its acquisition of Allgreens Dispensary, LLC on April 9, 2024. The approval of the license transfer by the Illinois Department of Financial & Professional Regulation, and subsequent closing of the acquisition, allows MariMed to fully consolidate the financial results of the Company’s Thr
